Phase 2 Study of IDH305 in Low Grade Gliomas

Stopped Sponsor did not want to move forward with protocol; study was never opened.

Conditions

• Glioma

Interventions

• DRUG: IDH305

Sponsor

University of Texas Southwestern Medical Center